BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T100000
DTEND;TZID=America/New_York:20201117T110000
DTSTAMP:20260403T201208
CREATED:20201104T141806Z
LAST-MODIFIED:20201110T151145Z
UID:4546-1605607200-1605610800@carb-x.org
SUMMARY:CARB-X WEBINAR: Tackling Drug-resistant Bacteria: Exciting Science in the CARB-X Portfolio - Vedanta\, Eligo\, Peptilogics
DESCRIPTION:Join us Tuesday\, November 17\, at 10 AM – 11 AM ET for an update on CARB-X\, and an insider’s look at 3 innovative programs supported by CARB-X \nCARB-X is hosting this special webinar to showcase some of the exciting science in the CARB-X portfolio and the progress CARB-X is making supporting the development of innovative therapeutics\, preventatives and rapid diagnostics to address antibiotic-resistant bacteria. \nThe webinar will be moderated by Kevin Outterson\, Executive Director of CARB-X\, and will feature \n\nErin Duffy\, CARB-X R&D Chief\, on portfolio priorities and progress\nXavier Duportet\, Co-Founder and CEO of Eligo Bioscience\, on Eligo’s innovative CRISPR-based therapeutics derived from bacteriophages to prevent and treat antibiotic-resistant infections in transplant patients\nJonathan Steckbeck\, Founder and CEO of Peptilogics\, on the development of their first-in-class antibiotic peptide for the treatment of prosthetic joint infections which recently was granted Orphan Drug Designation by the US Food and Drug Administration\nBernat Olle\, Co-Founder and CEO of Vedanta Biosciences\, on Vedanta’s microbiome program\, including VE707\, an oral therapeutic designed to restore a patient’s healthy microbiota to that it can fight multidrug-resistant bacteria\, and VE303\, which has recently become the first CARB-X-funded therapeutic to go on to secure BARDA support for late-stage development\, and is also the first-ever BARDA award for research and development of a live bio-therapeutic product.\n\nA virtual Q&A will also be held. \nCLICK HERE TO REGISTER TODAY:\nOnce you register\, you will receive a confirmation and will be able to download an invitation to your calendar.
URL:https://carb-x.org/event/carb-x-webinar-tackling-drug-resistant-bacteria-exciting-science-in-the-carb-x-portfolio/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T110000
DTEND;TZID=America/New_York:20201117T123000
DTSTAMP:20260403T201208
CREATED:20201026T143033Z
LAST-MODIFIED:20201026T143155Z
UID:4511-1605610800-1605616200@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Discovery of new antibacterials using artificial intelligence (computational chemoinformatics)
DESCRIPTION:Speakers: \n\nJames J. Collins\, Termeer Professor of Medical Engineering & Science Professor\, Broad Institute of MIT and Harvard (USA)\nCesar de la Fuente\, Presidential Assistant Professor\, University of Pennsylvania (USA)\nHenriette Willems\, Senior Research Associate\, The ALBORADA Drug Discovery Institute\, University of Cambridge\, (UK)\nFredrik Svensson\, Senior Research Associate\, UCL Drug Discovery Institute\, London\, (UK)\n\nModerator:  \n\nLaura Piddock\, Director of Scientific Affairs\, GARDP\n\nIn this webinar\, the speakers will give an overview of their work on the discovery of antibiotics through the use of artificial intelligence. The session will include the following presentations: \n\nDeep learning approaches to antibiotic discovery – James J. Collins\nAntibiotic discovery by means of computers – Cesar de la Fuente\nComputational Chemistry on a Budget – Henriette Willems & Fredrik Svensson\n\nTo learn more\, click here. 
URL:https://carb-x.org/event/live-webinar-gardp-revive-discovery-of-new-antibacterials-using-artificial-intelligence-computational-chemoinformatics/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR